The Phase 2b ADAPTIVE trial is a randomized, placebo-controlled dose-finding study designed to evaluate the efficacy and safety of various dose regimens of IMG-007 in adults with moderate-to-severe AD ...

-- 63% complete response (CR) rate at any time (n=62); -- 56% CR rate at 3 months (n=62); -- 62% CR rate at 6 months (n=37), with 4 patients having successfully converted to CR post reinduction; and - ...

Join us Dec. 8 for Federal News Network's Industry Exchange Cloud event where top technology leaders will discuss latest cloud breakthroughs and strategies for the future. Register now!

Since September 25, open carry without a permit has been legal in most public spaces, with familiar carve-outs for “sensitive ...

New laws, firings and pressure facing universities across Texas mirror historic conflicts over academic freedom that reshaped UT eight decades ago. Here's how.

Professor Tom Alter is appealing to Texas’s Board of Regents after being temporarily reinstated and then fired again.

The founders of this country would be proud to know that the system they set up more than 200 years ago is still being used today for events like the ...

A legislative committee voted unanimously on Thursday to order South Dakota’s secretary of state to answer questions about ...

CBD company Charlotte’s Web Holdings Inc. (TSX: CWEB) has appointed M. Borgia Walker, chief people officer at tobacco company Reynolds American Inc., to its board of directors.

Please note that the views of outside contributors do not reflect the official opinions of SCOTUSblog or its staff. To understand why, we need to delve a little deeper into the legal issues in play.

Columbia University reached a $200 million deal with the Trump administration in July. The Knight First Amendment Institute was among those concerned that it would hamper the school's autonomy. Though ...